Croda International, a London-listed specialty chemicals company, has announced a decrease in pretax profit attributed to lowering sales caused by customers reducing inventory levels. In addition to this, the company anticipates a decline in its adjusted operating margin by two to three percentage points in 2024 due to various year-on-year business mix effects.
Impact of Covid-19 on Sales and Profit
Croda stated that there will be no Covid-19 lipid contributions this year. Moreover, sales volumes in its crop protection and industrial specialties sectors are expected to remain low, further impacting the overall performance of the business.
Financial Overview for 2023
- Pretax Profit: £236.3 million, compared to £780.0 million the previous year
- Adjusted Pretax Profit: £308.8 million, down from £496.1 million
- Revenue: £1.69 billion, a decrease from £2.09 billion
The company's performance was aligned with the consensus estimates gathered from analysts' forecasts.
Dividend Update
Despite the challenging financial results, Croda International announced an increase in its final dividend to 109 pence per share from 108 pence.
For more information, please visit Croda International's website.
Abrdn Financial Performance Report
Air Liquide Share Capital Increase
Our Latest News
Tesla's Year-End Push: Incentives to Drive Sales
As Tesla faces the challenge of meeting year-end expectations, they are offering attractive incentives to boost sales.
UnitedHealth Group: A Thriving Health Insurance Company
Investors can find protection and potential returns by investing in defensive stocks. Morgan Stanley's screening process identifies top picks for stability and...
Microsoft Corp. Shares Rise Despite Overall Poor Trading Session
Shares of Microsoft Corp. showed resilience as they inched 0.37% higher in a downtrending market session. The trading volume also exceeded the average, indicati...